Enpr-EMA Coordinating Group meeting March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 March 2024, 15:30 (CET) to 4 March 2024, 17:00 (CET)

Committee for Advanced Therapies (CAT): 13-15 March 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2024 to 15 March 2024

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Organisation chart of the European Medicines Agency

Development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisations

Scientific guidelines for veterinary medicines

Concept paper for the development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisations

Confidentiality arrangement between the EU and the Republic of Korea

Working arrangement between the Ministry of Food and Drug Safety of the Republic of Korea and the Directorate-General for Health and Food Safety of the European Commission and EMA for the Exchange of Non-Public Information on Medicinal Products

Guidance on the anonymisation of protected personal data and assessment of commercially confidential information during the preparation of RMPs (main body and annexes 4 and 6)